Position in EXEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$443,249,867
+$111,036,151 QoQ
Shares Held
8,146,478
+5.2% QoQ
Ownership
3.29%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#9
of 751 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. EXEL ranks #3 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,275,145 | $548,241,690 | |
| 2 | INCY |
Incyte Corp
|
4,123,759 | $467,469,320 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
8,146,478 | $443,249,867 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
253,200 | $157,880,328 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,410,257 | $110,380,815 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,061,242 | $75,049,821 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
881,700 | $50,450,874 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
721,666 | $28,231,573 |
All Filings in EXEL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,249,867 | 8,146,478 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $332,213,716 | 7,745,715 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $339,504,199 | 7,745,932 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $320,844,295 | 7,768,627 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $344,725,303 | 7,820,447 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $301,316,598 | 8,161,338 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $272,055,905 | 8,169,847 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $210,256,683 | 8,102,377 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $129,510,968 | 5,763,728 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $65,843,797 | 2,774,707 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,800,711 | 158,429 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,672,434 | 1,037,640 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $24,221,447 | 1,267,475 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $40,884,913 | 2,106,384 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $40,303,435 | 2,512,683 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $31,910,336 | 2,035,098 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $37,350,268 | 1,793,961 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $12,871,776 | 567,789 | Shares | Sole | 2022-05-12 | |
| 2020-09-30 | $1,863,090 | 76,200 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,808,988 | 76,200 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,312,164 | 76,200 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||